Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sorting nexin 18 pseudogene 24 (SNX18P24) is classified as a pseudogene. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they do not encode a functional protein product. SNX18P24 is related by sequence to the sorting nexin 18 (SNX18) gene, a member of the sorting nexin family, which is involved in intracellular membrane trafficking. However, SNX18P24 itself does not produce a protein and is not recognized as a therapeutic target. SNX18P24 is specifically annotated as a pseudogene in major gene databases. Pseudogenes such as SNX18P24 are not directly involved in coding functional proteins, nor do they serve as targets for therapeutics, disease biomarkers, or drug development. The functional, protein-coding relative "SNX18" (sorting nexin 18) belongs to the sorting nexin protein family, involved in intracellular trafficking. Only "SNX18," not "SNX18P24," is reported to have biological function or involvement in disease. There are no reported drugs, biological functions, or disease associations for SNX18P24, consistent with its non-coding, pseudogene status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sorting nexin 18 pseudogene 24 (SNX18P24).